ATA221181A - Verfahren zur herstellung von einer pharmazeutischen zusammensetzung - Google Patents

Verfahren zur herstellung von einer pharmazeutischen zusammensetzung

Info

Publication number
ATA221181A
ATA221181A AT0221181A AT221181A ATA221181A AT A221181 A ATA221181 A AT A221181A AT 0221181 A AT0221181 A AT 0221181A AT 221181 A AT221181 A AT 221181A AT A221181 A ATA221181 A AT A221181A
Authority
AT
Austria
Prior art keywords
producing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT0221181A
Other languages
English (en)
Other versions
AT374682B (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ATA221181A publication Critical patent/ATA221181A/de
Application granted granted Critical
Publication of AT374682B publication Critical patent/AT374682B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0221181A 1980-05-16 1981-05-18 Verfahren zur herstellung einer pharmazeutischen zusammensetzung AT374682B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (2)

Publication Number Publication Date
ATA221181A true ATA221181A (de) 1983-10-15
AT374682B AT374682B (de) 1984-05-25

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0221181A AT374682B (de) 1980-05-16 1981-05-18 Verfahren zur herstellung einer pharmazeutischen zusammensetzung

Country Status (21)

Country Link
US (1) US4360523A (de)
JP (1) JPS579716A (de)
AT (1) AT374682B (de)
AU (1) AU543726B2 (de)
BE (1) BE888832A (de)
CA (1) CA1160571A (de)
CH (1) CH647677A5 (de)
DE (1) DE3119510A1 (de)
DK (1) DK159376C (de)
FI (1) FI70793C (de)
FR (1) FR2482458A1 (de)
GB (1) GB2076288B (de)
GR (1) GR75658B (de)
IE (1) IE51285B1 (de)
IT (1) IT1170970B (de)
LU (1) LU83363A1 (de)
NL (1) NL8102362A (de)
NZ (1) NZ196985A (de)
SE (1) SE460457B (de)
YU (1) YU44831B (de)
ZA (1) ZA813188B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
DE3819842C1 (de) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006002887A1 (en) * 2004-06-29 2006-01-12 Baxter International Inc. Aqueous drink solution of indibulin (d-24851) and an organic acid
MX2007005434A (es) * 2004-11-08 2007-07-10 Baxter Int Composiciones de nanoparticulado de inhibidor de tubulina.
EP2091532A1 (de) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Verwendung von indolyl-3-glyoxylsäure-derivaten einschliesslich indibulin, allein oder in kombination mit weiteren mitteln zur behandlung von krebs
US10434077B2 (en) 2014-03-31 2019-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
NL8102362A (nl) 1981-12-16
JPH0136445B2 (de) 1989-07-31
AU7029181A (en) 1981-11-19
JPS579716A (en) 1982-01-19
DE3119510A1 (de) 1982-02-25
GB2076288A (en) 1981-12-02
YU112381A (en) 1985-03-20
FI811474L (fi) 1981-11-17
GB2076288B (en) 1983-12-14
IT1170970B (it) 1987-06-03
IE811092L (en) 1981-11-16
YU44831B (en) 1991-04-30
CA1160571A (en) 1984-01-17
CH647677A5 (de) 1985-02-15
AT374682B (de) 1984-05-25
NZ196985A (en) 1983-06-17
DK216681A (da) 1981-11-17
AU543726B2 (en) 1985-05-02
BE888832A (fr) 1981-11-16
FR2482458B1 (de) 1984-12-14
IT8148467A0 (it) 1981-05-14
LU83363A1 (fr) 1982-01-20
DK159376C (da) 1991-03-25
FI70793B (fi) 1986-07-18
ZA813188B (en) 1982-05-26
GR75658B (de) 1984-08-02
SE460457B (sv) 1989-10-16
IE51285B1 (en) 1986-11-26
US4360523A (en) 1982-11-23
SE8103071L (sv) 1981-11-17
FR2482458A1 (fr) 1981-11-20
DK159376B (da) 1990-10-08
DE3119510C2 (de) 1991-03-07
FI70793C (fi) 1986-10-27

Similar Documents

Publication Publication Date Title
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
AT380476B (de) Verfahren zur herstellung von chinazolinderivaten
DE3230888A1 (de) Verfahren zur herstellung von verbundstoffen
AT385659B (de) Verfahren zur herstellung einer therapeutischen zusammensetzung
AT377263B (de) Verfahren zur herstellung von n-phosphonomethyl- glycin
ATA221181A (de) Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
AT374827B (de) Verfahren zur herstellung von cholesterase
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT367436B (de) Verfahren zur herstellung von copolymerisaten
DD137670A5 (de) Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung
AT380005B (de) Verfahren zur herstellung von gipsprodukten
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
AT380686B (de) Verfahren zur herstellung von buspiron
AT388160B (de) Verfahren zur herstellung von isobutyrylfluorid
AT375328B (de) Verfahren zur herstellung von sintermagnesia
ATA110780A (de) Verfahren zur herstellung von o-trimethylsilyl- -cellulosen
ATA221080A (de) Verfahren zur herstellung einer pharmazeutischen zubereitung
ATA132381A (de) Verfahren zur herstellung von baumaterialien
AT383735B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
ATA328581A (de) Verfahren zur herstellung von 1-phenoxy-3-amino- 2-propanolen
ATA535281A (de) Verfahren zur herstellung von phenoxyisobutters|ureestern
AT370716B (de) Verfahren zur herstellung von naphthacendionderivaten
ATA206087A (de) Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
AT369383B (de) Verfahren zur herstellung von beta-amidoethyl -ether-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification